Abstract
Purpose
To evaluate whether the status of the external limiting membrane (ELM) or inner segment/outer segment junction (IS/OS) improves after intravitreal injection of ranibizumab for age-related macular degeneration (AMD). We also evaluated whether the pre-operative values of these parameters are associated with the visual prognosis.
Methods
This was a hospital-based, cross-sectional study. Seventy-six eyes of 76 treatment-naive AMD patients who received three monthly intravitreal injections of ranibizumab followed for more than 6 months with additional as-needed injections were investigated. Spectral domain OCT was used to evaluate the length of ELM, IS/OS, and foveal thickness pre- and post-operatively. Changes of ELM and IS/OS length were evaluated postoperatively. Correlation coefficients between pre-operative parameters and post-operative visual acuity were also analyzed.
Results
Significant changes were noted in mean logMAR (0.66 to 0.53), foveal thickness (231.1 to 151.1 μm), and IS/OS length (514.9 to 832.3 μm) after the treatment. ELM length did not improve significantly (1,312.4 to 1,376.7 μm). Restoration of IS/OS occured where ELM is retained. Although pre-operative ELM length, IS/OS length, and foveal thickness showed correlation with post-operative logMAR (R = –0.51, –0.39, and 0.46, respectively), the most powerful predictive factor for visual prognosis was pre-operative logMAR (R = 0.77, p < 0.001).
Conclusions
IS/OS status improves in response to anti-VEGF therapy but ELM seems to have less plasticity. The status of IS/OS and ELM can be used as prognostic factors but the predictive power is inferior to that of baseline visual acuity.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Optical coherence tomography (OCT) is widely used to assess microstructural changes in the retina, especially that of macular pathologies. Since the era of time-domain OCT, which had limited axial resolution of up to 10 μm, the device has been a standard tool in clinical practice [1] and in the management of age-related macular degeneration (AMD) [2–5]. Moreover, currently available spectral-domain OCT machines achieve up to 5-μm resolution and allow layer-by-layer evaluation of the retina [6, 7].
In AMD, photoreceptor integrity, as indicated by the retinal layer pattern, is important for vision. Several groups have shown that continuity of the junction between inner and outer segments of the photoreceptors (IS/OS) is associated with good visual acuity (VA) in AMD patients who were treated with PDT [8] or with anti-VEGF agents [9]. Another group used microperimetry and confirmed the association of IS/OS status and retinal sensitivity [10]. Our group has reported that intact ELM as well as IS/OS is important for good vision [11]. Evaluation of these retinal changes provides detailed information and more profound understanding of retinal pathologies [12, 13].
The treatment of AMD drastically changed after two pivotal studies showed marked effects of anti-vascular endothelial growth factor (VEGF) therapy [14–16]. The treatment enabled not only maintenance of vision but also improvement in patients with any subtype of AMD over a 24-month period [14–16]. Although the relatively high cost of the drug and the need for ongoing intravitreal injections are demanding [17], no other treatment has achieved these levels of visual acuity gain [18], and thus the treatment is now a first-line choice for AMD.
Given the improvement in vision, it is clear that anti-VEGF therapy is beneficial for the retina. However, how the therapy affects retinal microstructures such as IS/OS or ELM has not been evaluated. Evaluation of these microstructures would provide more detailed information about the retinal changes during the treatment course and could help identify the potential for plasticity of these structures, i.e., how much photoreceptor damage could be recovered with the current standard treatment regimen. In addition, if the morphologic changes during the treatment process are consistent, we may be able to predict visual prognosis from pre-operative findings because post-operative retinal morphology is associated with post-operative vision [8, 9, 11].
In the present study, we investigated quantitatively the changes of IS/OS and ELM after treatment. We also examined pre-operative findings and visual prognosis to test whether these morphological features can be used as predictive factors.
Methods
All procedures conformed to the tenets of the Declaration of Helsinki and the study design was approved by the institutional review board of Kobe City Medical Center General Hospital. The review board waived the need for written informed consent because the study design consisted of retrospective chart review.
We retrospectively reviewed the clinical records of patients who underwent three monthly injections of ranibizumab for AMD from February 2009 to February 2011 and were followed for more than 6 months at Kobe City Medical Center General Hospital. Diagnosis of AMD was made with funduscopy, slit-lamp examination, OCT, and fluorescein/indocyanine green angiography. Patients who were under 50 years old or who had refractive error less than –6 diopters or axial length more than 26.5 mm were not considered as having AMD. Only patients who were examined with SD-OCT before and after a follow-up period of more than 6 months were included in the study. Exclusion criteria included other retinal or optic nerve diseases such as retinal vein occlusion, diabetic retinopathy, or optic neuropathy. Those who were previously treated with photodynamic therapy or laser photocoagulation and who dropped out from the treatment regimen were also excluded. SD-OCT images were obtained with Spectralis: Spectralis Family Acquisition Module (version 4.0.2.0, Heidelberg Engineering, Dossenheim, Germany) with Heidelberg Eye Explorer (version 1.6.1.0). Horizontal scans of the macula were recorded for each eye. The measurements were performed under pupillary dilation. The eye tracking ART (automatic real time) software of the device was used to assure that the scans made were in the correct position and averagings were properly done; the position of the fovea was manually detected during examination. We routinely averaged 60 scans per image and when the examination failed to average more than 40 images or to scan the foveola due to poor fixation or media opacity, the patients were excluded from the study.
We measured the length of ELM and IS/OS within regions of 1 mm nasal and temporal from the fovea (Fig. 1). Measurement of ELM and IS/OS length was manually done using software built in the OCT. To investigate the diagnostic value of qualitative evaluation, whether each line is continuous or disrupted at fovea were also investigated. Foveal thickness was defined as the distance between the vitreoretinal border and the edge of the retinal pigment epithelium. When retinal detachment or sub-retinal fibrosis was seen, the inner border of the subretinal fluid or fibrosis was used as the outer boundary. To evaluate the reproducibility and inter-examiner variability for the measurements, two independent examiners (A.O. and M.S.), who were masked as to the VA of the study participants, measured the above parameters and inter-observer variation was calculated. The average of two measures was used for the statistical analysis. In addition, images from 20 randomly selected patients were re-measured by the same examiner (M.S.) 2 months after the first measurement and intra-observer variability was calculated. Clinical characteristics, including age, sex, and angiographic classification: occult with no classic, minimally classic, and predominantly classic were also reviewed and analyzed. To detect maximal changes after the treatment, the image with least exudative changes was selected for each patient and evaluated as the post-operative image. Selection of the images with least exudative changes was done by two of the authors (A.O. and M.S.) and always coincided.
Statistical analysis was performed using IBM SPSS Statistics Desktop (version 19.0.0; IBM Japan, Tokyo, Japan). Descriptive analyses are reported as means ± standard deviation unless otherwise specified. Visual acuities were measured with a Landolt C chart and then converted to logarithm of the minimum angle of resolution (logMAR) equivalents. Bivariate relationships were examined using Spearman’s rank correlation coefficient. Intra- and inter-examiner variability was tested using intraclass correlation coefficients ICC(1,1) and ICC(2,1), respectively. Group means for each measurement were compared using one-way analysis of variance (ANOVA) with Bonferroni correction. p values of less than 0.05 were considered to be statistically significant.
Results
We reviewed 144 eyes of 144 patients who were planned to undergo three monthly induction and as-needed additional treatment. After the exclusion of 11 patients with a poor-quality image, 45 patients with previous treatment, and 12 patients who dropped out from the treatment regimen, a total of 76 eyes of 76 patients with AMD met the inclusion criteria. The mean age of the enrolled patients was 77.3 ± 9.6 years; there were 45 men and 31 women. Pre-operative logMAR was 0.67 ± 0.41. Thirty-four eyes were classified as occult with no classic, 17 as minimally classic, and 25 as predominantly classic. Foveal thickness was 231.1 ± 136.2 μm. The ELM length was 1,312.4 ± 660.3 μm and the IS/OS length was 514.9 ± 574.2 μm. The inter-examiner measurements were highly correlated; intraclass correlation coefficients between the measurements by two of the authors were 0.84 for ELM and 0.89 for IS/OS. Intra-examiner correlation coefficients were 0.85 for ELM and 0.93 for IS/OS.
IS/OS was disrupted at fovea in 56 cases and ELM in 30 cases. Disruption of each line at fovea was associated with poor logMAR (0.76 ± 0.40 in IS/OS disrupted and 0.39 ± 0.31 in IS/OS continuous cases, p < 0.001; 0.92 ± 0.41 in ELM disrupted and 0.49 ± 0.31 in ELM continuous cases, p < 0.001) ELM was almost always (74 of 76 cases) longer than IS/OS; when IS/OS was preserved, they were almost always accompanied by ELM. Those with occult with no classic lesion had longer ELM (1,580.6 ± 516.9 μm) and IS/OS (677.3 ± 646.2 μm) compared to those with minimally classic lesion (ELM: 1,115.3 ± 657.8 μm, p = 0.04; IS/OS: 258.1 ± 422.2 μm, p = 0.04) or predominantly classic lesion (ELM: 1,081.7 ± 722.4 μm, p = 0.01; IS/OS: 468.7 ± 501.0 μm, p = 0.48).
The participants underwent 4.2 ± 1.2 intravitreal injections during the observation period of 7.7 ± 1.9 months. LogMAR improved to 0.53 ± 0.41. Foveal thickness decreased to 151.1 ± 48.5 μm, p < 0.001, probably reflecting the resolution of retinal edema [19] (Fig. 2). IS/OS length increased to 832.3 ± 743.3 μm, p < 0.001. In other words, the IS/OS recovered approximately 60 % of its continuity (Fig. 3). On the other hand, post-operative ELM length was 1,376.7 ± 654.6 μm and was not significantly different from pre-operative measurements. There was no significant difference in ELM and IS/OS improvements (post-operative length minus pre-operative length) among occult and classic lesions. Foveal disruption of IS/OS (n = 46) and ELM (n = 26) was again associated with visual acuity (0.74 ± 0.37 in IS/OS disrupted and 0.21 ± 0.21 in IS/OS continuous cases, p < 0.001; 0.94 ± 0.34 in ELM disrupted and 0.31 ± 0.25 in ELM continuous cases, p < 0.001). Pre-operative or post-operative foveal disruption of ELM or IS/OS made no difference in ELM or IS/OS improvement.
Since the mean ELM length did not show significant changes, we further assessed the status of the ELM in individual cases. We reviewed the images of 19 eyes that showed more than 300-μm improvement of the ELM (based on the standard deviation SD of the difference between the two observers: 289.9 μm). These cases, in the pre-operative state, typically showed abnormalities in the outer retina that could complicate the interpretation (Fig. 4). In fact, 12 cases had subretinal fibrin like material, four cases had CME, two cases had subretinal fibrovascular lesion, and two cases had accumulation of exudates (some cases had combinations of these). We cannot tell whether the ELM had defects or if the ELM was only invisible due to these masking factors in these cases.
We also investigated 38 eyes, which showed more than 300-μm IS/OS restoration. Fibirin, CME, subretinal fibrovascular lesion, and/or accumulation of exudates were also noted in these eyes (16, 10, two, and six eyes, respectively). The influences of these masking factors were again suspected in these cases. In addition, IS/OS restoration was observed only in area where ELM existed post-operatively but pre-operative ELM preservation was not a pre-requisite for IS/OS recovery.
We then assessed the prognostic value of these parameters. Pre-operative foveal thickness, ELM length, and IS/OS length were associated with post-operative logMAR (R = 0.46, p < 0.001; R = –0.51, p < 0.001; R = –0.39, p = 0.001, respectively). However, pre-operative logMAR showed a stronger correlation (R = 0.77, p < 0.001). When we performed a multiple linear-regression analysis, factors other than pre-operative logMAR did not show significant effects on post-operative logMAR. The adjusted R 2 for the model was 0.59; the standardized regression coefficient of pre-operative logMAR was 0.77, p < 0.001.
Discussion
We evaluated the changes of OCT-depicted retinal structures, especially ELM and IS/OS, after anti-VEGF therapy. The results indicated that the IS/OS improves in response to the treatment; however, ELM has less plasticity. The study also showed the prognostic potential of these factors, although the predictive power seemed inferior to that of pre-operative visual acuity.
Anti-VEGF therapy is now a first-line treatment for AMD [20]. With the treatment regimen, retinal thickness improved and some of the IS/OS disturbance recovered. The plastic capacity of the IS/OS is plausible considering that outer segments reproduce daily and it takes less than 10 days for complete renewal [21]. In addition, the recovery of IS/OS always occurred where ELM existed. The finding confirms the notion that healthy photoreceptor is needed to produce outer segments and presence of ELM can be an indicator of photoreceptor integrity. It would be interesting to see if the notion is applicable in other diseases.
On the other hand, ELM seemed to have limited plasticity; ELM length did not change significantly and false-positive effects were frequently suspected in the individual cases where ELM improved. The result suggested that ELM disruption indicates more severe damage to photoreceptor cell bodies and it should be more difficult, if possible as we reported in closed MH [22], to overcome. Given that we do not have a way to directly regenerate the damaged retina, treatment should be as early as possible to avoid irreversible changes in the photoreceptors.
Predicting the visual prognosis from pre-operative OCT findings is of clinical interest in the management of AMD [23–26]. In the present study, foveal disruption of each line was associated with visual acuity in pre-operative or post-operative state, consistent with previous reports [8–11]. In addition, we showed that foveal thickness, length of ELM, and length of IS/OS have prognostic value for vision. However, pre-operative visual acuity showed stronger correlation with visual prognosis, consistent with the previous notion that OCT or angiography alone does not offer sufficient prediction of function [27]. The result from the present multiple regression analysis suggested that pre-operative OCT findings are confounding factors of pre-operative logMAR. Thus, although we can roughly predict visual prognosis from OCT findings, checking pre-operative visual acuity seems to be the most efficient way at present. Some modifications including refinement of image resolution [28] or combination of parameters would be needed for practical use.
There are several limitations to the present study, including the retrospective study design, a relatively small population from a single institution, and the use of the Landolt C chart for VA measurement rather than the ETDRS chart used in major clinical trials. Another limitation is the very nature of OCT examinations. The device depicts only a difference in light reflectance. Thus, disturbance of the ELM or IS/OS detected in OCT images does not necessarily indicate the disturbance of photoreceptors in a histopathologic context. We should keep in mind that these features are just parameters and not necessarily anatomic changes. Clinical relevance and histologic interpretation of the findings should be considered differently.
Additionally, there were difficulties in manual measurement of ELM or IS/OS length. When compared to more orderly images, as seen in epiretinal membrane (ERM) or macular hole (MH), AMD-affected retinas often were accompanied by fibrin, hemorrhage, or hard exudates, which make the interpretation of retinal structures difficult. The improvement of these lines can be a result of better visualization rather than histologic recovery. In addition, the images are often not in alignment due to subretinal fluid or hemorrhage. Although we confirmed the inter- and intra-observer reproducibility of the results, measurements were less consistent when compared to our previous experience dealing with ERM [29] or MH [22].
Finally, we have shown that the IS/OS improves in response to treatment but ELM has less plasticity. The result warrants further investigations for treatment strategies to enable ELM recovery. We have also shown the prognostic value of OCT parameters for visual outcome although the predictive power seemed inferior to that of initial visual acuity. Further development in the resolution of OCT images, identification of other factors, and/or a combination of the factors is needed to enhance this prognostic value.
References
Coker JG, Duker JS (1996) Macular disease and optical coherence tomography. Curr Opin Ophthalmol 7:33–38
Salinas-Alamán A, Garcia-Layana A, Maldonado MJ, Sainz-Gomez C, Alvarez-Vidal A (2005) Using optical coherence tomography to monitor photodynamic therapy in age-related macular degeneration. Am J Ophthalmol 140:23–28
Kashani AH, Keane PA, Dustin L, Walsh AC, Sadda SR (2009) Quantitative subanalysis of intraretinal cystoid spaces and outer nuclear layer using optical coherence tomography in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 50:3366–3373
Landa G, Bukelman A, Katz H, Pollack A (2009) Early OCT changes of neuroretinal foveal thickness after first versus repeated PDT in AMD. Int Ophthalmol 29:1–5
Keane PA, Liakopoulos S, Jivrajka RV, Chang KT, Alasil T, Walsh AC, Sadda SR (2009) Evaluation of optical coherence tomography central retinal thickness parameters for use as anatomic outcomes in clinical trials for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 50:3378–3385
Drexler W, Sattmann H, Hermann B, Ko TH, Stur M, Unterhuber A, Scholda C, Findl O, Wirtitsch M, Fujimoto JG, Fercher AF (2003) Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. Arch Ophthalmol 121:695–706
Ko TH, Fujimoto JG, Schuman JS, Paunescu LA, Kowalevicz AM, Hartl I, Drexler W, Wollstein G, Ishikawa H, Duker JS (2005) Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology. Ophthalmology 112:1922
Hayashi H, Yamashiro K, Tsujikawa A, Ota M, Otani A, Yoshimura N (2009) Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration. Am J Ophthalmol 148:83–89
Sayanagi K, Sharma S, Kaiser PK (2009) Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration. Br J Ophthalmol 93:622–626
Landa G, Su E, Garcia PM, Seiple WH, Rosen RB (2011) Inner segment-outer segment junctional layer integrity and corresponding retinal sensitivity in dry and wet forms of age-related macular degeneration. Retina 31:364–370
Oishi A, Hata M, Shimozono M, Mandai M, Nishida A, Kurimoto Y (2010) The significance of external limiting membrane status for visual acuity in age-related macular degeneration. Am J Ophthalmol 150:27–32
Coscas G, Coscas F, Vismara S, Zourdani A, Li Calzi C (2009) OCT interpretation. In: Coscas G, Coscas F, Vismara S, Zourdani A, Li Calzi C (eds) Optical coherence tomography in age-related macular degeneration. Springer, Berlin Heidelberg New York, pp 97–170
Coscas G, Coscas F, Vismara S, Zourdani A, Li Calzi C (2009) Clinical features and natural history of AMD. In: Coscas G, Coscas F, Vismara S, Zourdani A, Li Calzi C (eds) Optical coherence tomography in age-related macular degeneration. Springer, Berlin Heidelberg New York, pp 171–274
Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431
Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432–1444
Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T (2009) Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 116:57–65
Oishi A, Mandai M, Nishida A, Hata M, Matsuki T, Kurimoto Y (2011) Remission and dropout rate of anti-VEGF therapy for age-related macular degeneration. Eur J Ophthalmol 21:777–782
Bressler NM (2009) Antiangiogenic approaches to age-related macular degeneration today. Ophthalmology 116:S15–S23
Golbaz I, Ahlers C, Stock G, Schutze C, Schriefl S, Schlanitz F, Simader C, Prunte C, Schmidt-Erfurth UM (2011) Quantification of the therapeutic response of intraretinal, subretinal, and subpigment epithelial compartments in exudative AMD during anti-VEGF therapy. Invest Ophthalmol Vis Sci 52:1599–1605
Brown DM, Regillo CD (2007) Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol 144:627–637
Sung CH, Chuang JZ (2010) The cell biology of vision. J Cell Biol 190:953–963
Shimozono M, Oishi A, Hata M, Kurimoto Y (2011) Restoration of the photoreceptor outer segment and visual outcomes after macular hole closure: spectral-domain optical coherence tomography analysis. Graefes Arch Clin Exp Ophthalmol 249:1469–1476
Chiang A, Chang LK, Yu F, Sarraf D (2008) Predictors of anti-VEGF-associated retinal pigment epithelial tear using FA and OCT analysis. Retina 28:1265–1269
Moroz I, Moisseiev J, Alhalel A (2009) Optical coherence tomography predictors of retinal pigment epithelial tear following intravitreal bevacizumab injection. Ophthalmic Surg Lasers Imaging 40:570–575
Singh RP, Fu EX, Smith SD, Williams DR, Kaiser PK (2009) Predictive factors of visual and anatomical outcome after intravitreal bevacizumab treatment of neovascular age-related macular degeneration: an optical coherence tomography study. Br J Ophthalmol 93:1353–1358
Byun YJ, Lee SJ, Koh HJ (2010) Predictors of response after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Jpn J Ophthalmol 54:571–577
Unver YB, Yavuz GA, Bekiroglu N, Presti P, Li W, Sinclair SH (2009) Relationships between clinical measures of visual function and anatomic changes associated with bevacizumab treatment for choroidal neovascularization in age-related macular degeneration. Eye (Lond) 23:453–460
Keane PA, Liakopoulos S, Chang KT, Wang M, Dustin L, Walsh AC, Sadda SR (2008) Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration. Ophthalmology 115:2206–2214
Shimozono M, Oishi A, Hata M, Matsuki T, Ito S, Ishida K, Kurimoto Y (2012) The significance of cone outer segment tips as a prognostic factor in epiretinal membrane surgery. Am J Ophthalmol. doi:10.1016/j.ajo.2011.09.011
Acknowledgments
The study was supported in part by a Grant-In-Aid for Scientific Research (No. 22791706) from the Japanese Society for the Promotion of Science, Tokyo. Financial disclosures: none.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have no proprietary interest in any aspect of this study.
Rights and permissions
About this article
Cite this article
Oishi, A., Shimozono, M., Mandai, M. et al. Recovery of photoreceptor outer segments after anti-VEGF therapy for age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 251, 435–440 (2013). https://doi.org/10.1007/s00417-012-2034-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-012-2034-4